Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer

BACKGROUND: Many patients with incurable esophageal cancer (ECa) present with dysphagia as their predominant symptom. Currently there is no consensus on how best to initially manage this scenario with multiple therapeutic options available. We aimed to assess the safety and efficacy of using hypofra...

Descripción completa

Detalles Bibliográficos
Autores principales: Sridharan, Swetha, Day, Fiona, Loh, Jasmin, Lynam, James, Smart, Joanne, Holt, Brandan, Mandaliya, Hiren, Bonaventura, Anthony, Kumar, Mahesh, Martin, Jarad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472395/
https://www.ncbi.nlm.nih.gov/pubmed/36104707
http://dx.doi.org/10.1186/s13014-022-02127-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472395/
https://www.ncbi.nlm.nih.gov/pubmed/36104707
http://dx.doi.org/10.1186/s13014-022-02127-x

Ejemplares similares